Zobrazeno 1 - 10 of 833 pro vyhledávání: '"Parikh U"'
1
Akademický článek
Erdheim Chester disease presenting as bilateral breast dimpling and discoloration.
Autor: Oska C; Pembroke Pink Imaging, 15735 Pines Blvd, Pembroke Pines, FL 33027, USA., Parikh U; Pembroke Pink Imaging, 15735 Pines Blvd, Pembroke Pines, FL 33027, USA.
Publikováno v: Radiology case reports [Radiol Case Rep] 2024 Oct 25; Vol. 20 (1), pp. 289-291. Date of Electronic Publication: 2024 Oct 25 (Print Publication: 2025).
Zobrazit plný text záznamu
2
Akademický článek
Tailgut Cyst in a Child: A Case Report and Review of Literature.
Autor: Shukla R; Department of Paediatric Surgery, SVP Institute of Medical Sciences and Research, NHL Municipal Medical College, Ahmedabad, Gujarat, India., Patel JD; Department of General Surgery, SVP Institute of Medical Sciences and Research, NHL Municipal Medical College, Ahmedabad, Gujarat, India., Chandna SB; Department of Paediatric Surgery, SVP Institute of Medical Sciences and Research, NHL Municipal Medical College, Ahmedabad, Gujarat, India., Parikh U; Department of Paediatric Surgery, SVP Institute of Medical Sciences and Research, NHL Municipal Medical College, Ahmedabad, Gujarat, India.
Publikováno v: African journal of paediatric surgery : AJPS [Afr J Paediatr Surg] 2024 Jul 01; Vol. 21 (3), pp. 184-187. Date of Electronic Publication: 2024 Aug 09.
Zobrazit plný text záznamu
3
Akademický článek
An Efficient Deep Neural Network to Classify Large 3D Images With Small Objects.
Autor: Park J, Chledowski J, Jastrzebski S, Witowski J, Xu Y, Du L, Gaddam S, Kim E, Lewin A, Parikh U, Plaunova A, Chen S, Millet A, Park J, Pysarenko K, Patel S, Goldberg J, Wegener M, Moy L, Heacock L, Reig B, Geras KJ
Publikováno v: IEEE transactions on medical imaging [IEEE Trans Med Imaging] 2024 Jan; Vol. 43 (1), pp. 351-365. Date of Electronic Publication: 2024 Jan 02.
Zobrazit plný text záznamu
4
Akademický článek
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
Autor: Nair G; Stellenbosch University, Centre for Medical Ethics and Law, Stellenbosch, South Africa., Celum C; Department of Global Health, Department of Medicine, and Department of Epidemiology, University of Washington, Seattle, WA, USA. Electronic address: ccelum@uw.edu., Szydlo D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Brown ER; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Akello CA; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Nakalega R; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Macdonald P; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Milan G; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Palanee-Phillips T; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Epidemiology, University of Washington, Seattle, WA, USA., Reddy K; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Tahuringana E; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Muhlanga F; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Nakabiito C; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Siziba B; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Hillier SL; Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Baeten JM; Department of Global Health, Department of Medicine, and Department of Epidemiology, University of Washington, Seattle, WA, USA; Gilead Sciences, Foster City, CA, USA., Garcia M; FHI 360, Durham, NC, USA., Johnson S; FHI 360, Durham, NC, USA., McClure T; FHI 360, Durham, NC, USA., Levy L; FHI 360, Durham, NC, USA., Livant E; Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Jacobson C; Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Soto-Torres L; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., van der Straten A; ASTRA Consulting, Kensington, CA, USA; Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, CA, USA., Hosek S; Department of Medicine, University of Illinois, Chicago, IL, USA., Rooney JF; Gilead Sciences, Foster City, CA, USA., Steytler J; International Partnership for Microbicides, Johannesburg, South Africa., Bunge K; Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Parikh U; Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Hendrix C; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Anderson P; Department of Pharmacology, University of Colorado, Denver, CO, USA., Ngure K; Jomo Kenyatta University of Agriculture and Technology, School of Public Health, Nairobi, Kenya.
Publikováno v: The lancet. HIV [Lancet HIV] 2023 Dec; Vol. 10 (12), pp. e779-e789. Date of Electronic Publication: 2023 Oct 25.
Zobrazit plný text záznamu
5
Akademický článek
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.
Autor: Haidar G; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Jacobs JL; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Kramer KH; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Naqvi A; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Heaps A; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Parikh U; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., McCormick KD; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Sobolewski MD; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Agha M; Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Bogdanovich T; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Bushunow V; Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Farah R; Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Hensley M; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Hsu YS; Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Johnson B; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Klamar-Blain C; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Kozar J; Department of Pharmacy, Investigational Drug Services, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Lendermon E; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Macatangay BJC; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Marino CC; Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Raptis A; Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Salese E; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Silveira FP; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Leen AM; Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA., Marshall WL; CinCor, Inc, Waltham, Massachusetts, USA., Miller M; AlloVir, Inc, Waltham, Massachusetts, USA., Patel B; AlloVir, Inc, Waltham, Massachusetts, USA., Atillasoy E; AlloVir, Inc, Waltham, Massachusetts, USA., Mellors JW; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Sep 11; Vol. 77 (5), pp. 696-702.
Zobrazit plný text záznamu
6
Akademický článek
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction.
Autor: Steytler J; International Partnership for Microbicides South Africa NPC, Johannesburg, South Africa., Craig C; Research Virology Consulting Ltd, Cambridgeshire, United Kingdom., van der Ryst E; Independent Consultant, Kent, United Kingdom., Van Baelen B; BVB Clin Consult BVBA, Herent, Belgium., Nuttall J; International Partnership for Microbicides, Silver Spring, Maryland, USA., van Niekerk N; International Partnership for Microbicides South Africa NPC, Johannesburg, South Africa., Mellors J; Microbicide Trials Network Virology Core Laboratory, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Parikh U; Microbicide Trials Network Virology Core Laboratory, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Wallis C; Bio-Analytical Research Corporation Laboratory and Lancet Laboratories, Johannesburg, South Africa.
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Mar 21; Vol. 76 (6), pp. 996-1002.
Zobrazit plný text záznamu
7
Akademický článek
Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.
Autor: Delaney KE; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa., Ngobeni T; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa., Woods CK; University of British Columbia, Vancouver, British Columbia, Canada., Gordijn C; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa., Claassen M; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa., Parikh U; University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Harrigan PR; University of British Columbia, Vancouver, British Columbia, Canada., van Zyl GU; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa.
Publikováno v: Tropical medicine & international health : TM & IH [Trop Med Int Health] 2023 Mar; Vol. 28 (3), pp. 186-193. Date of Electronic Publication: 2023 Jan 13.
Zobrazit plný text záznamu
8
Akademický článek
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials-The Ring Study and DREAM.
Autor: Steytler J; International Partnership for Microbicides South Africa NPC, Johannesburg, South Africa., van der Ryst E; Independent Consultant, Kent., Craig C; Research Virology Consulting Ltd, Cambridgeshire, United Kingdom., Van Baelen B; BVB Clin Consult BVBA, Herent, Belgium., Nuttall J; International Partnership for Microbicides, Silver Spring, Maryland, USA., van Niekerk N; International Partnership for Microbicides South Africa NPC, Johannesburg, South Africa., Mellors J; Microbicide Trials Network Virology Core Laboratory, University of Pittsburgh, Pennsylvania, USA., Parikh U; Microbicide Trials Network Virology Core Laboratory, University of Pittsburgh, Pennsylvania, USA., Wallis C; Bio-Analytical Research Corporation Laboratory, Johannesburg, South Africa.
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Feb 08; Vol. 76 (3), pp. 389-397.
Zobrazit plný text záznamu
9
Akademický článek
Incidence of hemoglobinopathies in women attending antenatal clinics in their first trimester.
Autor: Parikh, U. R.1, Goswami, H. M.2, Mehta, R. C.3, Patel, P. S.1, Gonsai, R. N.4
Publikováno v: NHL Journal of Medical Sciences. Jan2014, Vol. 3 Issue 1, p63-67. 5p.
Zobrazit plný text záznamu
10
Akademický článek
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
Autor: Thurman AR; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Brache V; Profamilia, Santo Domingo, Dominican Republic., Cochon L; Profamilia, Santo Domingo, Dominican Republic., Ouattara LA; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Chandra N; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Jacot T; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Yousefieh N; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Clark MR; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Peet M; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Hanif H; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Schwartz JL; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Ju S; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America., Marzinke MA; Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Erikson DW; Endocrine Technologies Core (ETC), Oregon National Primate Research Center (ONPRC), Beaverton, OR, United States of America., Parikh U; Department of Medicine, Division of Infectious Diseases and Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA, United States of America., Herold BC; Albert Einstein College of Medicine, Bronx, NY, United States of America., Fichorova RN; Laboratory of Genital Tract Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America., Tolley E; Family Health International 360, Research Triangle, NC, United States of America., Doncel GF; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
Publikováno v: PloS one [PLoS One] 2022 Oct 10; Vol. 17 (10), pp. e0275794. Date of Electronic Publication: 2022 Oct 10 (Print Publication: 2022).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje